NCT03380507View on ClinicalTrials.gov

Evaluation of Hydrocortisone, Vitamin C and Thiamine for the Treatment of Septic Shock

PHASE2/PHASE3TerminatedINTERVENTIONAL
Enrollment

106

Participants

Timeline

Start Date

March 17, 2018

Primary Completion Date

October 3, 2019

Study Completion Date

November 1, 2021

Conditions
Septic ShockCritical Illness
Interventions
DRUG

Triple therapy group

Refer to arms description

Trial Locations (1)

3050

Hamad Medical Corporation, Doha

Sponsors
All Listed Sponsors
lead

Hamad Medical Corporation

INDUSTRY

NCT03380507 - Evaluation of Hydrocortisone, Vitamin C and Thiamine for the Treatment of Septic Shock | Biotech Hunter | Biotech Hunter